Author Affiliations: Baxter Laboratory for Stem Cell Biology, Stanford University School of Medicine, Stanford, California (Dr Blau); and Department of Surgery, University of California, San Francisco (Dr Pomerantz).
The potential to regenerate damaged limbs and hearts seems the subject of science fiction, but newts and zebrafish do it all the time. What can scientists learn from these simple creatures? Why have mammals not retained this remarkably useful property in the course of evolution? Can an evolutionary perspective on the mechanisms used by “lowly” organisms inform the approach to human tissue regeneration? Could this lead to the generation of abundant patient-specific differentiated cells for cell therapy, for elucidating disease mechanisms, for therapeutic drug screening? Recent studies suggest that this is possible.1- 3
Blau HM, Pomerantz JH. Re“evolutionary” Regenerative Medicine. JAMA. 2011;305(1):87–88. doi:10.1001/jama.2010.1938
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.